Astrazeneca PLC 20-F annual reports
The annual report filed by foreign private issuers listed on a US exchange — the 10-K’s equivalent for non-US companies.
NYSE
AstraZeneca appoints KPMG as its external auditor, replacing PricewaterhouseCoopers after a competitive tender process.
NYSE
AstraZeneca PLC's 20-F filing highlights strong financial performance, strategic initiatives, and key developments in its pipeline and sustainability efforts.
NYSE
20-F: AstraZeneca Highlights Commitment to Science, Sustainability, and Ethical Practices in Annual Report
AstraZeneca's annual report emphasizes its dedication to scientific innovation, sustainability, and ethical conduct, showcasing its financial performance and strategic priorities.